KR102591077B1 - Cosmetic composition - Google Patents
Cosmetic composition Download PDFInfo
- Publication number
- KR102591077B1 KR102591077B1 KR1020230083884A KR20230083884A KR102591077B1 KR 102591077 B1 KR102591077 B1 KR 102591077B1 KR 1020230083884 A KR1020230083884 A KR 1020230083884A KR 20230083884 A KR20230083884 A KR 20230083884A KR 102591077 B1 KR102591077 B1 KR 102591077B1
- Authority
- KR
- South Korea
- Prior art keywords
- weight
- extract
- skin
- cosmetic composition
- parts
- Prior art date
Links
- 239000000203 mixture Substances 0.000 title claims abstract description 61
- 239000002537 cosmetic Substances 0.000 title claims abstract description 56
- 239000003795 chemical substances by application Substances 0.000 claims abstract description 32
- 239000002826 coolant Substances 0.000 claims abstract description 24
- 230000003750 conditioning effect Effects 0.000 claims abstract description 21
- 239000000932 sedative agent Substances 0.000 claims abstract description 20
- 239000000516 sunscreening agent Substances 0.000 claims abstract description 20
- 102000008186 Collagen Human genes 0.000 claims abstract description 17
- 108010035532 Collagen Proteins 0.000 claims abstract description 17
- 229920001436 collagen Polymers 0.000 claims abstract description 17
- 230000001624 sedative effect Effects 0.000 claims abstract description 17
- 229920002385 Sodium hyaluronate Polymers 0.000 claims abstract description 12
- 229960005188 collagen Drugs 0.000 claims abstract description 12
- RWSXRVCMGQZWBV-WDSKDSINSA-N glutathione Chemical compound OC(=O)[C@@H](N)CCC(=O)N[C@@H](CS)C(=O)NCC(O)=O RWSXRVCMGQZWBV-WDSKDSINSA-N 0.000 claims abstract description 12
- 229940010747 sodium hyaluronate Drugs 0.000 claims abstract description 12
- YWIVKILSMZOHHF-QJZPQSOGSA-N sodium;(2s,3s,4s,5r,6r)-6-[(2s,3r,4r,5s,6r)-3-acetamido-2-[(2s,3s,4r,5r,6r)-6-[(2r,3r,4r,5s,6r)-3-acetamido-2,5-dihydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-2-carboxy-4,5-dihydroxyoxan-3-yl]oxy-5-hydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-3,4,5-trihydroxyoxane-2- Chemical compound [Na+].CC(=O)N[C@H]1[C@H](O)O[C@H](CO)[C@@H](O)[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@H](O[C@H]2[C@@H]([C@@H](O[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@H](O3)C(O)=O)O)[C@H](O)[C@@H](CO)O2)NC(C)=O)[C@@H](C(O)=O)O1 YWIVKILSMZOHHF-QJZPQSOGSA-N 0.000 claims abstract description 12
- 230000000475 sunscreen effect Effects 0.000 claims abstract description 10
- ACTIUHUUMQJHFO-UHFFFAOYSA-N Coenzym Q10 Natural products COC1=C(OC)C(=O)C(CC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)C)=C(C)C1=O ACTIUHUUMQJHFO-UHFFFAOYSA-N 0.000 claims abstract description 7
- ACTIUHUUMQJHFO-UPTCCGCDSA-N coenzyme Q10 Chemical compound COC1=C(OC)C(=O)C(C\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CCC=C(C)C)=C(C)C1=O ACTIUHUUMQJHFO-UPTCCGCDSA-N 0.000 claims abstract description 7
- 235000017471 coenzyme Q10 Nutrition 0.000 claims abstract description 7
- NPCOQXAVBJJZBQ-UHFFFAOYSA-N reduced coenzyme Q9 Natural products COC1=C(O)C(C)=C(CC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)C)C(O)=C1OC NPCOQXAVBJJZBQ-UHFFFAOYSA-N 0.000 claims abstract description 7
- 229940035936 ubiquinone Drugs 0.000 claims abstract description 7
- 102000016942 Elastin Human genes 0.000 claims abstract description 6
- 108010014258 Elastin Proteins 0.000 claims abstract description 6
- 108010024636 Glutathione Proteins 0.000 claims abstract description 6
- 241000186660 Lactobacillus Species 0.000 claims abstract description 6
- YJPIGAIKUZMOQA-UHFFFAOYSA-N Melatonin Natural products COC1=CC=C2N(C(C)=O)C=C(CCN)C2=C1 YJPIGAIKUZMOQA-UHFFFAOYSA-N 0.000 claims abstract description 6
- ATGQXSBKTQANOH-UWVGARPKSA-N N-oleoylphytosphingosine Chemical compound CCCCCCCCCCCCCC[C@@H](O)[C@@H](O)[C@H](CO)NC(=O)CCCCCCC\C=C/CCCCCCCC ATGQXSBKTQANOH-UWVGARPKSA-N 0.000 claims abstract description 6
- 229920002549 elastin Polymers 0.000 claims abstract description 6
- 229960003180 glutathione Drugs 0.000 claims abstract description 6
- 229940039696 lactobacillus Drugs 0.000 claims abstract description 6
- DRLFMBDRBRZALE-UHFFFAOYSA-N melatonin Chemical compound COC1=CC=C2NC=C(CCNC(C)=O)C2=C1 DRLFMBDRBRZALE-UHFFFAOYSA-N 0.000 claims abstract description 6
- 229960003987 melatonin Drugs 0.000 claims abstract description 6
- 229920002683 Glycosaminoglycan Polymers 0.000 claims abstract description 5
- KIUKXJAPPMFGSW-DNGZLQJQSA-N (2S,3S,4S,5R,6R)-6-[(2S,3R,4R,5S,6R)-3-Acetamido-2-[(2S,3S,4R,5R,6R)-6-[(2R,3R,4R,5S,6R)-3-acetamido-2,5-dihydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-2-carboxy-4,5-dihydroxyoxan-3-yl]oxy-5-hydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-3,4,5-trihydroxyoxane-2-carboxylic acid Chemical compound CC(=O)N[C@H]1[C@H](O)O[C@H](CO)[C@@H](O)[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@H](O[C@H]2[C@@H]([C@@H](O[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@H](O3)C(O)=O)O)[C@H](O)[C@@H](CO)O2)NC(C)=O)[C@@H](C(O)=O)O1 KIUKXJAPPMFGSW-DNGZLQJQSA-N 0.000 claims description 23
- 229920002674 hyaluronan Polymers 0.000 claims description 23
- 229960003160 hyaluronic acid Drugs 0.000 claims description 23
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 claims description 16
- OIRDTQYFTABQOQ-KQYNXXCUSA-N adenosine Chemical compound C1=NC=2C(N)=NC=NC=2N1[C@@H]1O[C@H](CO)[C@@H](O)[C@H]1O OIRDTQYFTABQOQ-KQYNXXCUSA-N 0.000 claims description 16
- -1 alkylene glycol Chemical compound 0.000 claims description 15
- GWEVSGVZZGPLCZ-UHFFFAOYSA-N Titan oxide Chemical compound O=[Ti]=O GWEVSGVZZGPLCZ-UHFFFAOYSA-N 0.000 claims description 13
- TVXBFESIOXBWNM-UHFFFAOYSA-N Xylitol Natural products OCCC(O)C(O)C(O)CCO TVXBFESIOXBWNM-UHFFFAOYSA-N 0.000 claims description 10
- HEBKCHPVOIAQTA-UHFFFAOYSA-N meso ribitol Natural products OCC(O)C(O)C(O)CO HEBKCHPVOIAQTA-UHFFFAOYSA-N 0.000 claims description 10
- 239000000811 xylitol Substances 0.000 claims description 10
- 235000010447 xylitol Nutrition 0.000 claims description 10
- HEBKCHPVOIAQTA-SCDXWVJYSA-N xylitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)CO HEBKCHPVOIAQTA-SCDXWVJYSA-N 0.000 claims description 10
- 229960002675 xylitol Drugs 0.000 claims description 10
- 229940008099 dimethicone Drugs 0.000 claims description 9
- 239000004205 dimethyl polysiloxane Substances 0.000 claims description 9
- 235000013870 dimethyl polysiloxane Nutrition 0.000 claims description 9
- 229920000435 poly(dimethylsiloxane) Polymers 0.000 claims description 9
- 241000512259 Ascophyllum nodosum Species 0.000 claims description 8
- 239000002126 C01EB10 - Adenosine Substances 0.000 claims description 8
- 244000004281 Eucalyptus maculata Species 0.000 claims description 8
- DFPAKSUCGFBDDF-UHFFFAOYSA-N Nicotinamide Chemical compound NC(=O)C1=CC=CN=C1 DFPAKSUCGFBDDF-UHFFFAOYSA-N 0.000 claims description 8
- 241000533293 Sesbania emerus Species 0.000 claims description 8
- 244000299461 Theobroma cacao Species 0.000 claims description 8
- 235000005764 Theobroma cacao ssp. cacao Nutrition 0.000 claims description 8
- 235000005767 Theobroma cacao ssp. sphaerocarpum Nutrition 0.000 claims description 8
- 241001106462 Ulmus Species 0.000 claims description 8
- 229960005305 adenosine Drugs 0.000 claims description 8
- 239000001140 aloe barbadensis leaf extract Substances 0.000 claims description 8
- 229940069638 aloe vera leaf extract Drugs 0.000 claims description 8
- 235000010323 ascorbic acid Nutrition 0.000 claims description 8
- 239000011668 ascorbic acid Substances 0.000 claims description 8
- 229960005070 ascorbic acid Drugs 0.000 claims description 8
- 229940021973 bay leaf extract Drugs 0.000 claims description 8
- 229940069765 bean extract Drugs 0.000 claims description 8
- 235000001046 cacaotero Nutrition 0.000 claims description 8
- 235000005152 nicotinamide Nutrition 0.000 claims description 8
- 239000011570 nicotinamide Substances 0.000 claims description 8
- 229960003966 nicotinamide Drugs 0.000 claims description 8
- 239000001883 pimenta racemosa mill. fruit leaf extract Substances 0.000 claims description 8
- 239000000049 pigment Substances 0.000 claims description 7
- 239000004094 surface-active agent Substances 0.000 claims description 6
- 239000004408 titanium dioxide Substances 0.000 claims description 6
- IIZPXYDJLKNOIY-JXPKJXOSSA-N 1-palmitoyl-2-arachidonoyl-sn-glycero-3-phosphocholine Chemical compound CCCCCCCCCCCCCCCC(=O)OC[C@H](COP([O-])(=O)OCC[N+](C)(C)C)OC(=O)CCC\C=C/C\C=C/C\C=C/C\C=C/CCCCC IIZPXYDJLKNOIY-JXPKJXOSSA-N 0.000 claims description 5
- SNPLKNRPJHDVJA-ZETCQYMHSA-N D-panthenol Chemical compound OCC(C)(C)[C@@H](O)C(=O)NCCCO SNPLKNRPJHDVJA-ZETCQYMHSA-N 0.000 claims description 5
- 230000003078 antioxidant effect Effects 0.000 claims description 5
- 229940059958 centella asiatica extract Drugs 0.000 claims description 5
- 239000000787 lecithin Substances 0.000 claims description 5
- 229940067606 lecithin Drugs 0.000 claims description 5
- 235000010445 lecithin Nutrition 0.000 claims description 5
- 235000019198 oils Nutrition 0.000 claims description 5
- 229940101267 panthenol Drugs 0.000 claims description 5
- 239000011619 pantothenol Substances 0.000 claims description 5
- 235000020957 pantothenol Nutrition 0.000 claims description 5
- 239000002904 solvent Substances 0.000 claims description 5
- 235000020238 sunflower seed Nutrition 0.000 claims description 5
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 5
- WSSJONWNBBTCMG-UHFFFAOYSA-N 2-hydroxybenzoic acid (3,3,5-trimethylcyclohexyl) ester Chemical compound C1C(C)(C)CC(C)CC1OC(=O)C1=CC=CC=C1O WSSJONWNBBTCMG-UHFFFAOYSA-N 0.000 claims description 4
- UVCJGUGAGLDPAA-UHFFFAOYSA-N ensulizole Chemical compound N1C2=CC(S(=O)(=O)O)=CC=C2N=C1C1=CC=CC=C1 UVCJGUGAGLDPAA-UHFFFAOYSA-N 0.000 claims description 4
- 229960000655 ensulizole Drugs 0.000 claims description 4
- 229960004881 homosalate Drugs 0.000 claims description 4
- CUNWUEBNSZSNRX-RKGWDQTMSA-N (2r,3r,4r,5s)-hexane-1,2,3,4,5,6-hexol;(z)-octadec-9-enoic acid Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO.OC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO.CCCCCCCC\C=C/CCCCCCCC(O)=O.CCCCCCCC\C=C/CCCCCCCC(O)=O.CCCCCCCC\C=C/CCCCCCCC(O)=O CUNWUEBNSZSNRX-RKGWDQTMSA-N 0.000 claims description 3
- OFEACQDMSUYJHD-KRWDZBQOSA-N (2s)-6-amino-2-(dodecylamino)hexanoic acid Chemical compound CCCCCCCCCCCCN[C@H](C(O)=O)CCCCN OFEACQDMSUYJHD-KRWDZBQOSA-N 0.000 claims description 3
- DMBUODUULYCPAK-UHFFFAOYSA-N 1,3-bis(docosanoyloxy)propan-2-yl docosanoate Chemical compound CCCCCCCCCCCCCCCCCCCCCC(=O)OCC(OC(=O)CCCCCCCCCCCCCCCCCCCCC)COC(=O)CCCCCCCCCCCCCCCCCCCCC DMBUODUULYCPAK-UHFFFAOYSA-N 0.000 claims description 3
- NCZPCONIKBICGS-UHFFFAOYSA-N 3-(2-ethylhexoxy)propane-1,2-diol Chemical compound CCCCC(CC)COCC(O)CO NCZPCONIKBICGS-UHFFFAOYSA-N 0.000 claims description 3
- UMVMVEZHMZTUHD-UHFFFAOYSA-N DL-Propylene glycol dibenzoate Chemical compound C=1C=CC=CC=1C(=O)OC(C)COC(=O)C1=CC=CC=C1 UMVMVEZHMZTUHD-UHFFFAOYSA-N 0.000 claims description 3
- XMSXQFUHVRWGNA-UHFFFAOYSA-N Decamethylcyclopentasiloxane Chemical compound C[Si]1(C)O[Si](C)(C)O[Si](C)(C)O[Si](C)(C)O[Si](C)(C)O1 XMSXQFUHVRWGNA-UHFFFAOYSA-N 0.000 claims description 3
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 claims description 3
- 241001278026 Starmerella bombicola Species 0.000 claims description 3
- 235000021355 Stearic acid Nutrition 0.000 claims description 3
- 239000007983 Tris buffer Substances 0.000 claims description 3
- 239000002738 chelating agent Substances 0.000 claims description 3
- 229940090934 diphenylsiloxy phenyl trimethicone Drugs 0.000 claims description 3
- 229940079784 disodium stearoyl glutamate Drugs 0.000 claims description 3
- WODOUQLMOIMKAL-FJSYBICCSA-L disodium;(2s)-2-(octadecanoylamino)pentanedioate Chemical compound [Na+].[Na+].CCCCCCCCCCCCCCCCCC(=O)N[C@H](C([O-])=O)CCC([O-])=O WODOUQLMOIMKAL-FJSYBICCSA-L 0.000 claims description 3
- LYCAIKOWRPUZTN-UHFFFAOYSA-N ethylene glycol Natural products OCCO LYCAIKOWRPUZTN-UHFFFAOYSA-N 0.000 claims description 3
- 229940100524 ethylhexylglycerin Drugs 0.000 claims description 3
- 239000008103 glucose Substances 0.000 claims description 3
- WGCNASOHLSPBMP-UHFFFAOYSA-N hydroxyacetaldehyde Natural products OCC=O WGCNASOHLSPBMP-UHFFFAOYSA-N 0.000 claims description 3
- QIQXTHQIDYTFRH-UHFFFAOYSA-N octadecanoic acid Chemical compound CCCCCCCCCCCCCCCCCC(O)=O QIQXTHQIDYTFRH-UHFFFAOYSA-N 0.000 claims description 3
- OQCDKBAXFALNLD-UHFFFAOYSA-N octadecanoic acid Natural products CCCCCCCC(C)CCCCCCCCC(O)=O OQCDKBAXFALNLD-UHFFFAOYSA-N 0.000 claims description 3
- 125000000913 palmityl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 claims description 3
- 229940057874 phenyl trimethicone Drugs 0.000 claims description 3
- 239000003755 preservative agent Substances 0.000 claims description 3
- 230000002335 preservative effect Effects 0.000 claims description 3
- 229940125723 sedative agent Drugs 0.000 claims description 3
- 229960005078 sorbitan sesquioleate Drugs 0.000 claims description 3
- 239000008117 stearic acid Substances 0.000 claims description 3
- 229960005196 titanium dioxide Drugs 0.000 claims description 3
- LINXHFKHZLOLEI-UHFFFAOYSA-N trimethyl-[phenyl-bis(trimethylsilyloxy)silyl]oxysilane Chemical compound C[Si](C)(C)O[Si](O[Si](C)(C)C)(O[Si](C)(C)C)C1=CC=CC=C1 LINXHFKHZLOLEI-UHFFFAOYSA-N 0.000 claims description 3
- UNZOESWLBMZBEY-YHZPTAEISA-N bis(16-methylheptadecyl) (z)-but-2-enedioate Chemical compound CC(C)CCCCCCCCCCCCCCCOC(=O)\C=C/C(=O)OCCCCCCCCCCCCCCCC(C)C UNZOESWLBMZBEY-YHZPTAEISA-N 0.000 claims description 2
- 239000006071 cream Substances 0.000 claims description 2
- 239000000839 emulsion Substances 0.000 claims description 2
- 239000003205 fragrance Substances 0.000 claims description 2
- 230000000887 hydrating effect Effects 0.000 claims description 2
- 239000006210 lotion Substances 0.000 claims description 2
- 229960004274 stearic acid Drugs 0.000 claims description 2
- 238000011282 treatment Methods 0.000 claims description 2
- 229940098780 tribehenin Drugs 0.000 claims description 2
- 244000281702 Dioscorea villosa Species 0.000 claims 2
- 239000003963 antioxidant agent Substances 0.000 claims 1
- 235000006708 antioxidants Nutrition 0.000 claims 1
- 125000003976 glyceryl group Chemical group [H]C([*])([H])C(O[H])([H])C(O[H])([H])[H] 0.000 claims 1
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 claims 1
- OBMZMSLWNNWEJA-XNCRXQDQSA-N C1=CC=2C(C[C@@H]3NC(=O)[C@@H](NC(=O)[C@H](NC(=O)N(CC#CCN(CCCC[C@H](NC(=O)[C@@H](CC4=CC=CC=C4)NC3=O)C(=O)N)CC=C)NC(=O)[C@@H](N)C)CC3=CNC4=C3C=CC=C4)C)=CNC=2C=C1 Chemical compound C1=CC=2C(C[C@@H]3NC(=O)[C@@H](NC(=O)[C@H](NC(=O)N(CC#CCN(CCCC[C@H](NC(=O)[C@@H](CC4=CC=CC=C4)NC3=O)C(=O)N)CC=C)NC(=O)[C@@H](N)C)CC3=CNC4=C3C=CC=C4)C)=CNC=2C=C1 OBMZMSLWNNWEJA-XNCRXQDQSA-N 0.000 abstract 1
- 101710176384 Peptide 1 Proteins 0.000 abstract 1
- 230000000694 effects Effects 0.000 description 27
- 230000032683 aging Effects 0.000 description 11
- 230000000052 comparative effect Effects 0.000 description 7
- 230000009759 skin aging Effects 0.000 description 7
- 240000005717 Dioscorea alata Species 0.000 description 6
- 206010051246 Photodermatosis Diseases 0.000 description 6
- 230000003020 moisturizing effect Effects 0.000 description 6
- 230000000903 blocking effect Effects 0.000 description 5
- 230000037303 wrinkles Effects 0.000 description 5
- 239000000843 powder Substances 0.000 description 4
- 230000003110 anti-inflammatory effect Effects 0.000 description 3
- 230000035597 cooling sensation Effects 0.000 description 3
- 230000007547 defect Effects 0.000 description 3
- 238000011156 evaluation Methods 0.000 description 3
- 239000004615 ingredient Substances 0.000 description 3
- SZVJSHCCFOBDDC-UHFFFAOYSA-N iron(II,III) oxide Inorganic materials O=[Fe]O[Fe]O[Fe]=O SZVJSHCCFOBDDC-UHFFFAOYSA-N 0.000 description 3
- 230000008845 photoaging Effects 0.000 description 3
- 230000004224 protection Effects 0.000 description 3
- 230000001953 sensory effect Effects 0.000 description 3
- 230000008591 skin barrier function Effects 0.000 description 3
- 230000037380 skin damage Effects 0.000 description 3
- NIXOWILDQLNWCW-UHFFFAOYSA-M Acrylate Chemical compound [O-]C(=O)C=C NIXOWILDQLNWCW-UHFFFAOYSA-M 0.000 description 2
- PNEYBMLMFCGWSK-UHFFFAOYSA-N Alumina Chemical compound [O-2].[O-2].[O-2].[Al+3].[Al+3] PNEYBMLMFCGWSK-UHFFFAOYSA-N 0.000 description 2
- UQSXHKLRYXJYBZ-UHFFFAOYSA-N Iron oxide Chemical compound [Fe]=O UQSXHKLRYXJYBZ-UHFFFAOYSA-N 0.000 description 2
- CSNNHWWHGAXBCP-UHFFFAOYSA-L Magnesium sulfate Chemical compound [Mg+2].[O-][S+2]([O-])([O-])[O-] CSNNHWWHGAXBCP-UHFFFAOYSA-L 0.000 description 2
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 2
- 206010040880 Skin irritation Diseases 0.000 description 2
- BGYHLZZASRKEJE-UHFFFAOYSA-N [3-[3-(3,5-ditert-butyl-4-hydroxyphenyl)propanoyloxy]-2,2-bis[3-(3,5-ditert-butyl-4-hydroxyphenyl)propanoyloxymethyl]propyl] 3-(3,5-ditert-butyl-4-hydroxyphenyl)propanoate Chemical compound CC(C)(C)C1=C(O)C(C(C)(C)C)=CC(CCC(=O)OCC(COC(=O)CCC=2C=C(C(O)=C(C=2)C(C)(C)C)C(C)(C)C)(COC(=O)CCC=2C=C(C(O)=C(C=2)C(C)(C)C)C(C)(C)C)COC(=O)CCC=2C=C(C(O)=C(C=2)C(C)(C)C)C(C)(C)C)=C1 BGYHLZZASRKEJE-UHFFFAOYSA-N 0.000 description 2
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 2
- TZCXTZWJZNENPQ-UHFFFAOYSA-L barium sulfate Chemical compound [Ba+2].[O-]S([O-])(=O)=O TZCXTZWJZNENPQ-UHFFFAOYSA-L 0.000 description 2
- RMBRKBNVOHGEJY-UHFFFAOYSA-N bis(3-docosanoyloxy-2-hydroxypropyl) icosanedioate Chemical compound CCCCCCCCCCCCCCCCCCCCCC(=O)OCC(O)COC(=O)CCCCCCCCCCCCCCCCCCC(=O)OCC(O)COC(=O)CCCCCCCCCCCCCCCCCCCCC RMBRKBNVOHGEJY-UHFFFAOYSA-N 0.000 description 2
- 238000001816 cooling Methods 0.000 description 2
- GVJHHUAWPYXKBD-UHFFFAOYSA-N d-alpha-tocopherol Natural products OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-UHFFFAOYSA-N 0.000 description 2
- 238000000855 fermentation Methods 0.000 description 2
- 230000004151 fermentation Effects 0.000 description 2
- 238000004519 manufacturing process Methods 0.000 description 2
- 239000010445 mica Substances 0.000 description 2
- 229910052618 mica group Inorganic materials 0.000 description 2
- 239000001301 oxygen Substances 0.000 description 2
- 229910052760 oxygen Inorganic materials 0.000 description 2
- SERHXTVXHNVDKA-UHFFFAOYSA-N pantolactone Chemical compound CC1(C)COC(=O)C1O SERHXTVXHNVDKA-UHFFFAOYSA-N 0.000 description 2
- 229940115458 pantolactone Drugs 0.000 description 2
- SIEVQTNTRMBCHO-UHFFFAOYSA-N pantolactone Natural products CC1(C)OC(=O)CC1O SIEVQTNTRMBCHO-UHFFFAOYSA-N 0.000 description 2
- 230000037394 skin elasticity Effects 0.000 description 2
- 230000036556 skin irritation Effects 0.000 description 2
- 231100000475 skin irritation Toxicity 0.000 description 2
- 235000010384 tocopherol Nutrition 0.000 description 2
- 229960001295 tocopherol Drugs 0.000 description 2
- 229930003799 tocopherol Natural products 0.000 description 2
- 239000011732 tocopherol Substances 0.000 description 2
- GVJHHUAWPYXKBD-IEOSBIPESA-N α-tocopherol Chemical compound OC1=C(C)C(C)=C2O[C@@](CCC[C@H](C)CCC[C@H](C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-IEOSBIPESA-N 0.000 description 2
- PUPZLCDOIYMWBV-UHFFFAOYSA-N (+/-)-1,3-Butanediol Chemical compound CC(O)CCO PUPZLCDOIYMWBV-UHFFFAOYSA-N 0.000 description 1
- 229940015975 1,2-hexanediol Drugs 0.000 description 1
- LQIAZOCLNBBZQK-UHFFFAOYSA-N 1-(1,2-Diphosphanylethyl)pyrrolidin-2-one Chemical compound PCC(P)N1CCCC1=O LQIAZOCLNBBZQK-UHFFFAOYSA-N 0.000 description 1
- JTHZUSWLNCPZLX-UHFFFAOYSA-N 6-fluoro-3-methyl-2h-indazole Chemical compound FC1=CC=C2C(C)=NNC2=C1 JTHZUSWLNCPZLX-UHFFFAOYSA-N 0.000 description 1
- 239000005995 Aluminium silicate Substances 0.000 description 1
- 240000000662 Anethum graveolens Species 0.000 description 1
- SGHZXLIDFTYFHQ-UHFFFAOYSA-L Brilliant Blue Chemical compound [Na+].[Na+].C=1C=C(C(=C2C=CC(C=C2)=[N+](CC)CC=2C=C(C=CC=2)S([O-])(=O)=O)C=2C(=CC=CC=2)S([O-])(=O)=O)C=CC=1N(CC)CC1=CC=CC(S([O-])(=O)=O)=C1 SGHZXLIDFTYFHQ-UHFFFAOYSA-L 0.000 description 1
- 201000004624 Dermatitis Diseases 0.000 description 1
- 206010015150 Erythema Diseases 0.000 description 1
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 description 1
- 239000004677 Nylon Substances 0.000 description 1
- 239000004698 Polyethylene Substances 0.000 description 1
- 239000004793 Polystyrene Substances 0.000 description 1
- 208000000453 Skin Neoplasms Diseases 0.000 description 1
- 230000006750 UV protection Effects 0.000 description 1
- 229910021536 Zeolite Inorganic materials 0.000 description 1
- RJDOZRNNYVAULJ-UHFFFAOYSA-L [O--].[O--].[O--].[O--].[O--].[O--].[O--].[O--].[O--].[O--].[F-].[F-].[Mg++].[Mg++].[Mg++].[Al+3].[Si+4].[Si+4].[Si+4].[K+] Chemical compound [O--].[O--].[O--].[O--].[O--].[O--].[O--].[O--].[O--].[O--].[F-].[F-].[Mg++].[Mg++].[Mg++].[Al+3].[Si+4].[Si+4].[Si+4].[K+] RJDOZRNNYVAULJ-UHFFFAOYSA-L 0.000 description 1
- XAGFODPZIPBFFR-UHFFFAOYSA-N aluminium Chemical compound [Al] XAGFODPZIPBFFR-UHFFFAOYSA-N 0.000 description 1
- 235000012211 aluminium silicate Nutrition 0.000 description 1
- 229910052788 barium Inorganic materials 0.000 description 1
- DSAJWYNOEDNPEQ-UHFFFAOYSA-N barium atom Chemical compound [Ba] DSAJWYNOEDNPEQ-UHFFFAOYSA-N 0.000 description 1
- HGKOWIQVWAQWDS-UHFFFAOYSA-N bis(16-methylheptadecyl) 2-hydroxybutanedioate Chemical compound CC(C)CCCCCCCCCCCCCCCOC(=O)CC(O)C(=O)OCCCCCCCCCCCCCCCC(C)C HGKOWIQVWAQWDS-UHFFFAOYSA-N 0.000 description 1
- DBZJJPROPLPMSN-UHFFFAOYSA-N bromoeosin Chemical compound O1C(=O)C2=CC=CC=C2C21C1=CC(Br)=C(O)C(Br)=C1OC1=C(Br)C(O)=C(Br)C=C21 DBZJJPROPLPMSN-UHFFFAOYSA-N 0.000 description 1
- 239000006229 carbon black Substances 0.000 description 1
- 230000036570 collagen biosynthesis Effects 0.000 description 1
- 229920001577 copolymer Polymers 0.000 description 1
- 229920006037 cross link polymer Polymers 0.000 description 1
- 230000006378 damage Effects 0.000 description 1
- 230000007423 decrease Effects 0.000 description 1
- HNPSIPDUKPIQMN-UHFFFAOYSA-N dioxosilane;oxo(oxoalumanyloxy)alumane Chemical compound O=[Si]=O.O=[Al]O[Al]=O HNPSIPDUKPIQMN-UHFFFAOYSA-N 0.000 description 1
- SZXQTJUDPRGNJN-UHFFFAOYSA-N dipropylene glycol Chemical compound OCCCOCCCO SZXQTJUDPRGNJN-UHFFFAOYSA-N 0.000 description 1
- LQJVOKWHGUAUHK-UHFFFAOYSA-L disodium 5-amino-4-hydroxy-3-phenyldiazenylnaphthalene-2,7-disulfonate Chemical compound [Na+].[Na+].OC1=C2C(N)=CC(S([O-])(=O)=O)=CC2=CC(S([O-])(=O)=O)=C1N=NC1=CC=CC=C1 LQJVOKWHGUAUHK-UHFFFAOYSA-L 0.000 description 1
- IVKWXPBUMQZFCW-UHFFFAOYSA-L disodium;2-(2,4,5,7-tetraiodo-3-oxido-6-oxoxanthen-9-yl)benzoate;hydrate Chemical compound O.[Na+].[Na+].[O-]C(=O)C1=CC=CC=C1C1=C2C=C(I)C(=O)C(I)=C2OC2=C(I)C([O-])=C(I)C=C21 IVKWXPBUMQZFCW-UHFFFAOYSA-L 0.000 description 1
- ANXXYABAFAQBOT-UHFFFAOYSA-N dodecyl-methyl-bis(trimethylsilyloxy)silane Chemical compound CCCCCCCCCCCC[Si](C)(O[Si](C)(C)C)O[Si](C)(C)C ANXXYABAFAQBOT-UHFFFAOYSA-N 0.000 description 1
- 230000002500 effect on skin Effects 0.000 description 1
- SEACYXSIPDVVMV-UHFFFAOYSA-L eosin Y Chemical compound [Na+].[Na+].[O-]C(=O)C1=CC=CC=C1C1=C2C=C(Br)C(=O)C(Br)=C2OC2=C(Br)C([O-])=C(Br)C=C21 SEACYXSIPDVVMV-UHFFFAOYSA-L 0.000 description 1
- 231100000321 erythema Toxicity 0.000 description 1
- 230000001747 exhibiting effect Effects 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 239000000796 flavoring agent Substances 0.000 description 1
- 235000013355 food flavoring agent Nutrition 0.000 description 1
- 230000006870 function Effects 0.000 description 1
- 238000010438 heat treatment Methods 0.000 description 1
- KWLMIXQRALPRBC-UHFFFAOYSA-L hectorite Chemical compound [Li+].[OH-].[OH-].[Na+].[Mg+2].O1[Si]2([O-])O[Si]1([O-])O[Si]([O-])(O1)O[Si]1([O-])O2 KWLMIXQRALPRBC-UHFFFAOYSA-L 0.000 description 1
- 229910000271 hectorite Inorganic materials 0.000 description 1
- FHKSXSQHXQEMOK-UHFFFAOYSA-N hexane-1,2-diol Chemical compound CCCCC(O)CO FHKSXSQHXQEMOK-UHFFFAOYSA-N 0.000 description 1
- 230000003834 intracellular effect Effects 0.000 description 1
- WTFXARWRTYJXII-UHFFFAOYSA-N iron(2+);iron(3+);oxygen(2-) Chemical compound [O-2].[O-2].[O-2].[O-2].[Fe+2].[Fe+3].[Fe+3] WTFXARWRTYJXII-UHFFFAOYSA-N 0.000 description 1
- JEIPFZHSYJVQDO-UHFFFAOYSA-N iron(III) oxide Inorganic materials O=[Fe]O[Fe]=O JEIPFZHSYJVQDO-UHFFFAOYSA-N 0.000 description 1
- NLYAJNPCOHFWQQ-UHFFFAOYSA-N kaolin Chemical compound O.O.O=[Al]O[Si](=O)O[Si](=O)O[Al]=O NLYAJNPCOHFWQQ-UHFFFAOYSA-N 0.000 description 1
- 229910052943 magnesium sulfate Inorganic materials 0.000 description 1
- 235000019341 magnesium sulphate Nutrition 0.000 description 1
- 238000000034 method Methods 0.000 description 1
- 238000002156 mixing Methods 0.000 description 1
- 229920001778 nylon Polymers 0.000 description 1
- 210000000056 organ Anatomy 0.000 description 1
- 239000012860 organic pigment Substances 0.000 description 1
- ZYIBVBKZZZDFOY-UHFFFAOYSA-N phloxine O Chemical compound O1C(=O)C(C(=C(Cl)C(Cl)=C2Cl)Cl)=C2C21C1=CC(Br)=C(O)C(Br)=C1OC1=C(Br)C(O)=C(Br)C=C21 ZYIBVBKZZZDFOY-UHFFFAOYSA-N 0.000 description 1
- 230000019612 pigmentation Effects 0.000 description 1
- 229920003229 poly(methyl methacrylate) Polymers 0.000 description 1
- 229920003217 poly(methylsilsesquioxane) Polymers 0.000 description 1
- 229920000573 polyethylene Polymers 0.000 description 1
- 239000004926 polymethyl methacrylate Substances 0.000 description 1
- 229920002223 polystyrene Polymers 0.000 description 1
- 230000002265 prevention Effects 0.000 description 1
- 230000001737 promoting effect Effects 0.000 description 1
- ULWHHBHJGPPBCO-UHFFFAOYSA-N propane-1,1-diol Chemical compound CCC(O)O ULWHHBHJGPPBCO-UHFFFAOYSA-N 0.000 description 1
- 239000000377 silicon dioxide Substances 0.000 description 1
- 201000000849 skin cancer Diseases 0.000 description 1
- 230000036560 skin regeneration Effects 0.000 description 1
- 235000013599 spices Nutrition 0.000 description 1
- 238000003756 stirring Methods 0.000 description 1
- 230000001502 supplementing effect Effects 0.000 description 1
- OGIDPMRJRNCKJF-UHFFFAOYSA-N titanium oxide Inorganic materials [Ti]=O OGIDPMRJRNCKJF-UHFFFAOYSA-N 0.000 description 1
- UUJLHYCIMQOUKC-UHFFFAOYSA-N trimethyl-[oxo(trimethylsilylperoxy)silyl]peroxysilane Chemical compound C[Si](C)(C)OO[Si](=O)OO[Si](C)(C)C UUJLHYCIMQOUKC-UHFFFAOYSA-N 0.000 description 1
- LENZDBCJOHFCAS-UHFFFAOYSA-N tris Chemical compound OCC(N)(CO)CO LENZDBCJOHFCAS-UHFFFAOYSA-N 0.000 description 1
- UJMBCXLDXJUMFB-UHFFFAOYSA-K trisodium;5-oxo-1-(4-sulfonatophenyl)-4-[(4-sulfonatophenyl)diazenyl]-4h-pyrazole-3-carboxylate Chemical compound [Na+].[Na+].[Na+].[O-]C(=O)C1=NN(C=2C=CC(=CC=2)S([O-])(=O)=O)C(=O)C1N=NC1=CC=C(S([O-])(=O)=O)C=C1 UJMBCXLDXJUMFB-UHFFFAOYSA-K 0.000 description 1
- 229960000281 trometamol Drugs 0.000 description 1
- 125000000391 vinyl group Chemical group [H]C([*])=C([H])[H] 0.000 description 1
- 229920002554 vinyl polymer Polymers 0.000 description 1
- 239000010457 zeolite Substances 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/67—Vitamins
- A61K8/676—Ascorbic acid, i.e. vitamin C
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/19—Cosmetics or similar toiletry preparations characterised by the composition containing inorganic ingredients
- A61K8/29—Titanium; Compounds thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
- A61K8/34—Alcohols
- A61K8/345—Alcohols containing more than one hydroxy group
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/40—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing nitrogen
- A61K8/42—Amides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/49—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds
- A61K8/4973—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with oxygen as the only hetero atom
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/55—Phosphorus compounds
- A61K8/553—Phospholipids, e.g. lecithin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/60—Sugars; Derivatives thereof
- A61K8/606—Nucleosides; Nucleotides; Nucleic acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/67—Vitamins
- A61K8/673—Vitamin B group
- A61K8/675—Vitamin B3 or vitamin B3 active, e.g. nicotinamide, nicotinic acid, nicotinyl aldehyde
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
- A61K8/73—Polysaccharides
- A61K8/735—Mucopolysaccharides, e.g. hyaluronic acid; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/92—Oils, fats or waxes; Derivatives thereof, e.g. hydrogenation products thereof
- A61K8/922—Oils, fats or waxes; Derivatives thereof, e.g. hydrogenation products thereof of vegetable origin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
- A61K8/97—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
- A61K8/9783—Angiosperms [Magnoliophyta]
- A61K8/9789—Magnoliopsida [dicotyledons]
Abstract
본 발명은 스킨 컨디셔닝제, 선 스크린제, 진정제, 쿨링제 및 스킨-팩터스 10을 포함하는 화장료 조성물에 관한 것으로, 상기 스킨 컨디셔닝제를 15 내지 25 중량부, 상기 선 스크린제를 20 내지 30 중량부, 상기 진정제를 0.001 내지 0.5 중량부, 상기 쿨링제를 0.001 내지 0.5 중량부, 상기 스킨-팩터스 10은 수화 콜라겐, 콜라겐, 소듐히알루로네이트, 세라마이드 NP, 하이드롤라이즈드엘라스틴, sh-올리고펩타이드-1, 락토바실러스발효물, 글라이코사미노글리칸, 유비퀴논, 멜라토닌, 및 글루타치온으로 이루어진 조성물인 화장료 조성물에 관한 것이다. The present invention relates to a cosmetic composition comprising a skin conditioning agent, a sunscreen, a sedative, a cooling agent, and Skin-Factors 10, wherein the skin conditioning agent is used in an amount of 15 to 25 parts by weight, and the sunscreen agent is used in an amount of 20 to 30 parts by weight. parts, 0.001 to 0.5 parts by weight of the sedative, 0.001 to 0.5 parts by weight of the cooling agent, the Skin-Factors 10 is hydrated collagen, collagen, sodium hyaluronate, ceramide NP, hydrolyzed elastin, sh-oligo It relates to a cosmetic composition consisting of peptide-1, Lactobacillus ferment, glycosaminoglycan, ubiquinone, melatonin, and glutathione.
Description
본 발명은 화장료 조성물에 관한 것이다. The present invention relates to cosmetic compositions.
피부의 노화 현상은 시간이 흐르면 노화하는 내인성(내적) 노화와 시간에 관계없이 노화하는 외인성(외적) 노화로 나뉠 수 있다. 내인성 노화는 나이를 먹음에 따라 자연스럽게 진행되는 노화로 인체의 모든 장기가 겪는 노화와 크게 다르지 않지만, 외인성 노화는 주로 태양광이라는 외적 원인에 의해 발생한다. 이중 외인성 노화가 내인성 노화에 비해 피부 노화에 보다 큰 영향을 미친다. 태양광에 의해 발생되는 광노화는 그 성분 중 하나인 자와선에 의해 발생되며, 자외선은 피부의 콜라겐과 엘라스틴의 양에 변화를 가하여 피부 노화 현상을 발생시킨다. The aging phenomenon of the skin can be divided into intrinsic (internal) aging, which occurs over time, and extrinsic (extrinsic) aging, which occurs regardless of time. Intrinsic aging is aging that occurs naturally as we age and is not much different from the aging experienced by all organs in the human body, but extrinsic aging is mainly caused by external causes such as sunlight. Among these, extrinsic aging has a greater impact on skin aging than intrinsic aging. Photoaging caused by sunlight is caused by one of its components, UV rays, and ultraviolet rays change the amount of collagen and elastin in the skin, causing skin aging.
피부가 자외선에 지속적으로 노출될 시에는 화상, 피부 흑화, 홍반, 콜라겐 파괴, 색소침착, 피부 광노화가 유발될 수 있고, 최악의 경우 피부암의 원인이 될 수 있으며, 이와 같은 자외선의 영향에 대한 소비자들의 인식이 높아지면서 자외선 차단제의 사용은 최근에는 필수로 여겨지고 있다. 그러나, 자외선 차단제는 기초화장 및 색조화장 후, 최종적으로 발라주어야 한다는 점에서 사용 순서를 따라야 하고, 기초화장 및 색조화장 외에 추가적으로 자외선 차단제를 사용하여 선 스크리닝을 하여야 한다는 번거로움이 있다. 특히, 자외선 차단제는 차후의 추가적인 피부 노화 현상을 방지할 뿐 이미 노화된 피부에 대한 개선 효과를 발휘하지는 못하므로, 별도의 피부 노화 개선을 위한 화장품 또는 시술이 요구된다. If the skin is continuously exposed to ultraviolet rays, it can cause burns, skin darkening, erythema, collagen destruction, pigmentation, and skin photoaging. In the worst case, it can cause skin cancer. Consumers are aware of the effects of ultraviolet rays. As people's awareness increases, the use of sunscreen has recently been considered essential. However, the order of use must be followed in that sunscreen must be applied finally after basic makeup and color makeup, and there is the inconvenience of having to use sunscreen in addition to basic makeup and color makeup for sunscreening. In particular, sunscreen only prevents additional skin aging in the future and does not have an improvement effect on already aged skin, so separate cosmetics or procedures for improving skin aging are required.
따라서, 피부의 결점을 커버해 주고 자외선 차단 효과를 제공하면서도, 동시에 이미 노화된 피부에 대한 개선 효과를 제공할 수 있는 새로운 화장료 조성물의 개발을 필요로 한다. Therefore, there is a need to develop a new cosmetic composition that can cover skin defects and provide UV protection, while also providing an improvement effect on already aged skin.
본 발명이 해결하고자 하는 과제는 스킨케어 효과 및 피부 결점 커버 효과와 함께 우수한 자외선 차단 효과를 발휘하는 화장료 조성물을 제공하는 것이다. The problem to be solved by the present invention is to provide a cosmetic composition that exhibits an excellent ultraviolet ray blocking effect along with a skin care effect and a skin defect covering effect.
본 발명은 상기 과제를 해결하기 위하여, 스킨 컨디셔닝제, 선 스크린제, 진정제, 쿨링제, 및 스킨-팩터스 10을 포함하는 화장료 조성물로서, 상기 스킨 컨디셔닝제를 15 내지 25 중량부, 상기 선 스크린제를 20 내지 30 중량부, 상기 진정제를 0.001 내지 0.1 중량부, 상기 쿨링제를 0.01 내지 0.5 중량부, 상기 스킨-팩터스 10을 0.01 내지 0.5 중량부 포함하고, 상기 스킨 컨디셔닝제는 아스코빅산, 판토락톤, 병풀추출물, 해바라기씨 오일, 자일리톨, 무수자일리톨, 수화 레시틴, 나이아신아미드, 판테놀, 아데노신, 히알루론산, 및 수화 히알루론산을 포함하고, 상기 선 스크린제는 티타늄디옥사이드, 호모살레이트, 및 페닐벤즈이미다졸설폰산을 포함하고, 상기 진정제는 카카오씨 추출물, 커피콩 추출물, 월계수잎 추출물 및 유칼리투스잎 추출물을 포함하고, 상기 쿨링제는 알로에베라잎 추출물, 참마뿌리 추출물, 다시마 추출물, 당느릅나무뿌리 추출물 및 제비꽃 꽃추출물을 포함하며, 상기 스킨-팩터스 10은 수화 콜라겐, 콜라겐, 소듐히알루로네이트, 세라마이드 NP, 하이드롤라이즈드엘라스틴, sh-올리고펩타이드-1, 락토바실러스발효물, 글라이코사미노글리칸, 유비퀴논, 멜라토닌, 및 글루타치온으로 이루어진 조성물인 화장료 조성물을 제공한다. In order to solve the above problems, the present invention is a cosmetic composition comprising a skin conditioning agent, a sunscreen agent, a sedative, a cooling agent, and Skin-Factor 10, wherein the skin conditioning agent is 15 to 25 parts by weight and the sunscreen. 20 to 30 parts by weight of the agent, 0.001 to 0.1 parts by weight of the sedative, 0.01 to 0.5 parts by weight of the cooling agent, and 0.01 to 0.5 parts by weight of the Skin-Factors 10, and the skin conditioning agent includes ascorbic acid, The sunscreen agent includes pantolactone, centella asiatica extract, sunflower seed oil, xylitol, anhydrous xylitol, hydrated lecithin, niacinamide, panthenol, adenosine, hyaluronic acid, and hydrated hyaluronic acid, and the sunscreen agent includes titanium dioxide, homosalate, and Contains phenylbenzimidazolesulfonic acid, the sedative agent includes cacao seed extract, coffee bean extract, bay leaf extract, and eucalyptus leaf extract, and the cooling agent includes aloe vera leaf extract, yam root extract, kelp extract, and sugar. It contains elm root extract and violet flower extract, and the Skin-Factors 10 contains hydrated collagen, collagen, sodium hyaluronate, ceramide NP, hydrolyzed elastin, sh-oligopeptide-1, Lactobacillus ferment, A cosmetic composition comprising glycosaminoglycan, ubiquinone, melatonin, and glutathione is provided.
본 발명의 화장료 조성물은 우수한 스킨케어 효과, 피부 결점 커버 효과 및 자외선 차단 효과와 함께 노화된 피부에 대한 개선 효과를 발휘하므로 자외선 차단 기능을 갖는 화장료 조성물로 유용하게 사용될 수 있다.The cosmetic composition of the present invention has an excellent skin care effect, skin defect covering effect, and ultraviolet ray blocking effect, as well as an improving effect on aged skin, so it can be usefully used as a cosmetic composition having a UV blocking function.
이하, 본 발명을 상세히 설명한다.Hereinafter, the present invention will be described in detail.
이하에서, 각 구성을 보다 상세히 설명하나, 이는 하나의 예시에 불과할 뿐, 본 발명의 권리범위가 다음 내용에 의해 제한되지 아니한다.Below, each configuration is described in more detail, but this is only an example, and the scope of the present invention is not limited by the following.
본 발명의 화장료 조성물은 스킨 컨디셔닝제를 15 내지 25 중량부, 선 스크린제를 20 내지 30 중량부, 진정제를 0.001 내지 0.1 중량부, 쿨링제를 0.01 내지 0.5 중량부, 스킨-팩터스 10을 0.01 내지 0.5 중량부 포함하고, 상기 스킨 컨디셔닝제는 아스코빅산, 판토락톤, 병풀추출물, 해바라기씨 오일, 자일리톨, 무수자일리톨, 수화 레시틴, 나이아신아미드, 판테놀, 아데노신, 히알루론산, 및 수화 히알루론산을 포함하고, 상기 선 스크린제는 티타늄디옥사이드, 호모살레이트, 및 페닐벤즈이미다졸설폰산을 포함하고, 상기 진정제는 카카오씨 추출물, 커피콩 추출물, 월계수잎 추출물 및 유칼리투스잎 추출물을 포함하고, 상기 쿨링제는 알로에베라잎 추출물, 참마뿌리 추출물, 다시마 추출물, 당느릅나무뿌리 추출물 및 제비꽃 꽃추출물을 포함하며, 상기 스킨-팩터스 10은 수화 콜라겐, 콜라겐, 소듐히알루로네이트, 세라마이드 NP, 하이드롤라이즈드엘라스틴, sh-올리고펩타이드-1, 락토바실러스발효물, 글라이코사미노글리칸, 유비퀴논, 멜라토닌, 및 글루타치온으로 이루어진 조성물이다. The cosmetic composition of the present invention contains 15 to 25 parts by weight of a skin conditioning agent, 20 to 30 parts by weight of a sunscreen, 0.001 to 0.1 parts by weight of a sedative, 0.01 to 0.5 parts by weight of a cooling agent, and 0.01 parts by weight of Skin-Factors 10. to 0.5 parts by weight, and the skin conditioning agent includes ascorbic acid, pantholactone, centella asiatica extract, sunflower seed oil, xylitol, anhydrous xylitol, hydrated lecithin, niacinamide, panthenol, adenosine, hyaluronic acid, and hydrated hyaluronic acid. The sunscreen agent includes titanium dioxide, homosalate, and phenylbenzimidazolesulfonic acid, the sedative agent includes cacao seed extract, coffee bean extract, bay leaf extract, and eucalyptus leaf extract, and the cooling agent includes The agent contains aloe vera leaf extract, yam root extract, kelp extract, elm root extract and violet flower extract, and the Skin-Factors 10 contains hydrating collagen, collagen, sodium hyaluronate, ceramide NP, and hydrolyze. It is a composition consisting of deelastin, sh-oligopeptide-1, Lactobacillus ferment, glycosaminoglycan, ubiquinone, melatonin, and glutathione.
본 발명의 화장료 조성물은 스킨 컨디셔닝제를 15 내지 25 중량부, 선 스크린제를 20 내지 30 중량부, 진정제를 0.001 내지 0.5 중량부, 쿨링제를 0.001 내지 0.5 중량부, 스킨-팩터스 10을 0.01 내지 0.5 중량부 포함하는 것으로, 자외선 차단 효과와 함께, 피부에 수분을 부여하고, 쿨링 효과를 발휘하며, 특히 상기 스킨-팩터스 10(skin-factors 10)을 포함하므로 태양 광선에 의한 피부 노화에 따른 주름 개선 효과를 발휘할 수 있다. The cosmetic composition of the present invention contains 15 to 25 parts by weight of a skin conditioning agent, 20 to 30 parts by weight of a sunscreen, 0.001 to 0.5 parts by weight of a sedative, 0.001 to 0.5 parts by weight of a cooling agent, and 0.01 parts by weight of Skin-Factors 10. Containing from 0.5 parts by weight, it has a UV blocking effect, provides moisture to the skin, and exerts a cooling effect. In particular, since it contains Skin-Factors 10, it protects against skin aging caused by solar rays. It can have a wrinkle-improving effect.
본 발명의 화장료 조성물은 상기 스킨 컨디셔닝제로서 아스코빅산, 판토락톤, 병풀추출물, 해바라기씨 오일, 자일리톨, 무수자일리톨, 수화 레시틴, 나이아신아미드, 판테놀, 아데노신, 히알루론산, 및 수화 히알루론산을 포함하여 피부 보습, 피부 진정 효과를 제공할 수 있다. The cosmetic composition of the present invention includes ascorbic acid, pantholactone, centella asiatica extract, sunflower seed oil, xylitol, anhydrous xylitol, hydrated lecithin, niacinamide, panthenol, adenosine, hyaluronic acid, and hydrated hyaluronic acid as the skin conditioning agent. It can provide skin moisturizing and skin soothing effects.
상기 스킨 컨디셔닝제가 아데노신을 포함할 경우, 상기 화장료 조성물이 피부 주름 개선에 도움을 줄 수 있다. 구체적으로 상기 아데노신은 상기 화장료 조성물 100 중량부를 기준으로 0.01 중량부 내지 1 중량부, 구체적으로 0.02 중량부 내지 0.8 중량부, 더욱 구체적으로 0.02 중량부 내지 0.5 중량부 포함할 수 있다. 상기 아데노신이 상기 함량 범위로 포함될 경우, 상기 화장료 조성물이 광노화 등에 따른 피부의 주름 개선에 더욱 효과적으로 도움을 줄 수 있다. When the skin conditioning agent contains adenosine, the cosmetic composition can help improve skin wrinkles. Specifically, the adenosine may include 0.01 to 1 part by weight, specifically 0.02 to 0.8 parts by weight, and more specifically 0.02 to 0.5 parts by weight, based on 100 parts by weight of the cosmetic composition. When the adenosine is included in the above content range, the cosmetic composition can more effectively help improve skin wrinkles caused by photoaging.
또한, 상기 스킨 컨디셔닝제가 히알루론산 및 수화 히알루론산을 포함할 경우, 상기 화장료 조성물에 보습 효과, 활성산소 제거 효과 및 피부 자극 완화 효과를 부여할 수 있다. In addition, when the skin conditioning agent contains hyaluronic acid and hydrated hyaluronic acid, the cosmetic composition can provide a moisturizing effect, an active oxygen removal effect, and a skin irritation alleviation effect.
본 발명의 화장료 조성물은 상기 스킨 컨디셔닝제에 포함되는 히알루론산 및 수화 히알루론산과 더불어 상기 스킨-팩터스 10에 포함되는 소듐히알루로네이트를 함께 포함하며, 따라서 상기 본 발명의 화장료 조성물은 히알루론산, 수화 히알루론산 및 소듐 히알루로네이트를 함께 포함하는 복합 히알루론산을 포함할 수 있다. The cosmetic composition of the present invention includes hyaluronic acid and hydrated hyaluronic acid included in the skin conditioning agent, as well as sodium hyaluronate included in Skin-Factors 10. Therefore, the cosmetic composition of the present invention contains hyaluronic acid, It may include complex hyaluronic acid comprising both hydrated hyaluronic acid and sodium hyaluronate.
상기 화장료 조성물은 서로 분자량 크기가 다른, 히알루론산(분자량;2,000 kDa), 수화 히알루론산 (분자량;7 kDa) 및 소듐 히아루로네이드(분자량;1,300 kDa)를 포함할 수 있다. 상기 히알루론산, 수화 히알루론산 및 소듐 히알루로네이트는 1:0.5:0.5 내지 1:2:2의 중량비로 포함될 수 있다. 상기 히알루론산, 수화 히알루론산 및 소듐 히알루로네이트가 상기 중량비를 만족할 경우, 더욱 우수한 보습 효과, 활성산소 제거 효과 및 피부 자극 완화 효과가 부여될 수 있다. The cosmetic composition may include hyaluronic acid (molecular weight: 2,000 kDa), hydrated hyaluronic acid (molecular weight: 7 kDa), and sodium hyaluronate (molecular weight: 1,300 kDa), which have different molecular weight sizes. The hyaluronic acid, hydrated hyaluronic acid, and sodium hyaluronate may be included in a weight ratio of 1:0.5:0.5 to 1:2:2. When the hyaluronic acid, hydrated hyaluronic acid, and sodium hyaluronate satisfy the above weight ratio, a more excellent moisturizing effect, active oxygen removal effect, and skin irritation alleviation effect can be provided.
본 발명의 화장료 조성물은 상기 스킨 컨디셔닝제로서 추가로 다이페닐실록시페닐트리메티콘, 페닐트리메티콘, 아스코빅산, 나이아신아미드, 프로필렌글리콜다이벤조에이트, 시클로펜타실록산, 디메티콘, 로릴 라이신, 트리베헤닌, 글리세릴베헤네이트/에이코사디오에이트, 디소듐스테아로일글루타메이트, 에틸헥실글리세린, 및 디아이소스테아릴말레이트를 추가로 포함할 수 있다. 상기 스킨 컨디셔닝제가 상기 성분을 추가로 포함할 경우, 더욱 우수한 피부 보습, 피부 진정 효과를 제공할 수 있다. The cosmetic composition of the present invention further contains diphenylsiloxyphenyltrimethicone, phenyltrimethicone, ascorbic acid, niacinamide, propylene glycol dibenzoate, cyclopentasiloxane, dimethicone, lauryl lysine, and trimethicone as the skin conditioning agent. It may further include behenin, glyceryl behenate/eicosadioate, disodium stearoyl glutamate, ethylhexylglycerin, and diisostearyl malate. When the skin conditioning agent additionally contains the above ingredients, it can provide better skin moisturizing and skin soothing effects.
상기 스킨 컨디셔닝제는 상기 화장료 조성물에 15 내지 25 중량부 포함되며, 구체적으로 16 내지 23 중량부, 더욱 구체적으로 18 중량부 내지 21 중량부 포함될 수 있다. 상기 스킨 컨디셔닝제가 상기 함량 범위로 포함될 경우 화장료 조성물이 우수한 피부 보습, 피부 진정 효과, 및 주름 개선 효과를 발휘할 수 있다. The skin conditioning agent may be included in the cosmetic composition in an amount of 15 to 25 parts by weight, specifically 16 to 23 parts by weight, and more specifically 18 to 21 parts by weight. When the skin conditioning agent is included in the above content range, the cosmetic composition can exhibit excellent skin moisturizing, skin soothing, and wrinkle improving effects.
상기 선 스크린제는 상기 화장료 조성물에 20 내지 30 중량부 포함되며, 구체적으로 23 내지 28 중량부, 더욱 구체적으로 25 내지 27 중량부 포함할 수 있다. 상기 선 스크린제가 상기 범위로 포함될 경우, 우수한 자외선 차단 효과를 발휘하면서도 화장료 조성물이 우수한 발림성을 발휘할 수 있다. The sunscreen agent may be included in the cosmetic composition in an amount of 20 to 30 parts by weight, specifically 23 to 28 parts by weight, and more specifically 25 to 27 parts by weight. When the sunscreen agent is included in the above range, the cosmetic composition can exhibit excellent spreadability while exhibiting an excellent UV blocking effect.
상기 진정제는 카카오씨 추출물, 커피콩 추출물, 월계수잎 추출물 및 유칼리투스잎 추출물을 포함하고, 또한 카카오씨 추출물, 커피콩 추출물, 월계수잎 추출물 및 유칼리투스잎 추출물을 1:1:1:1의 중량비로 포함할 수 있다. 상기 진정제는 카카오씨 추출물, 커피콩 추출물, 월계수잎 추출물 및 유칼리투스잎 추출물을 포함하므로, 피부 노화를 촉진시키는 활성 산소로부터 피부를 보호하는 항산화 효과, 피부의 염증 작용을 완화하여 피부를 맑고 깨끗하게 관리해주고, 청량한 피부 유지에 도움을 주는 항염 효과, 자외선으로 인한 피부 노화를 방지하여 주름 개선 및 피부 탄력 유지에 도움을 주는 광노화 방지 효과를 발휘할 수 있다. The sedative includes cacao seed extract, coffee bean extract, bay leaf extract, and eucalyptus leaf extract, and also includes cacao seed extract, coffee bean extract, bay leaf extract, and eucalyptus leaf extract in a weight ratio of 1:1:1:1. It can be included as . The sedative includes cacao seed extract, coffee bean extract, bay leaf extract, and eucalyptus leaf extract, so it has an antioxidant effect that protects the skin from free radicals that accelerate skin aging, and relieves skin inflammation to keep the skin clear and clean. It has an anti-inflammatory effect that helps maintain refreshing skin, and an anti-photoaging effect that helps improve wrinkles and maintain skin elasticity by preventing skin aging caused by ultraviolet rays.
상기 진정제는 상기 화장료 조성물에 0.001 내지 0.1 중량부 포함되며, 구체적으로 0.001 내지 0.05 중량부, 더욱 구체적으로 0.001 내지 0.01 중량부 포함될 수 있다. 상기 진정제가 상기 범위로 포함될 경우, 상기 항산화 효과, 항염 효과 및 광노화 방지 효과가 더욱 우수하게 발휘될 수 있다. The sedative may be included in the cosmetic composition in an amount of 0.001 to 0.1 parts by weight, specifically 0.001 to 0.05 parts by weight, and more specifically 0.001 to 0.01 parts by weight. When the sedative is included in the above range, the antioxidant effect, anti-inflammatory effect, and anti-photoaging effect can be more excellently demonstrated.
상기 쿨링제는 알로에베라잎 추출물, 참마뿌리 추출물, 다시마 추출물, 당느릅나무뿌리 추출물 및 제비꽃 꽃추출물을 포함하고, 구체적으로 쿨링제는 알로에베라잎 추출물, 참마뿌리 추출물, 다시마 추출물, 당느릅나무뿌리 추출물 및 제비꽃 꽃추출물을 1:1:1:1:1의 중량비로 포함할 수 있다. 상기 쿨링제는 알로에베라잎 추출물, 참마뿌리 추출물, 다시마 추출물, 당느릅나무뿌리 추출물 및 제비꽃 꽃추출물을 포함하므로, 피부의 온도를 낮춰 주어 쿨링감을 부여하고, 열 노화에 의한 피부 손상방지 효과를 발휘하며, 피부 진정 효과 및 피부 장벽 보호 효과를 발휘할 수 있다. The cooling agent includes aloe vera leaf extract, yam root extract, kelp extract, elm root extract, and violet flower extract. Specifically, the cooling agent includes aloe vera leaf extract, yam root extract, kelp extract, and elm root. Extract and violet flower extract may be included in a weight ratio of 1:1:1:1:1. Since the cooling agent includes aloe vera leaf extract, yam root extract, kelp extract, elm root extract, and violet flower extract, it lowers the temperature of the skin, provides a cooling sensation, and has the effect of preventing skin damage caused by heat aging. It can exert a skin soothing effect and skin barrier protection effect.
상기 쿨링제는 상기 화장료 조성물에 0.001 내지 0.5 중량부 포함되며, 구체적으로 0.001 내지 0.3 중량부, 더욱 구체적으로 0.001 내지 0.1 중량부 포함될 수 있다. 상기 쿨링제가 상기 범위로 포함될 경우, 더욱 우수한 쿨링감 부여, 피부 손상방지, 피부 진정 및 피부 장벽 보호 효과를 발휘할 수 있다. The cooling agent may be included in the cosmetic composition in an amount of 0.001 to 0.5 parts by weight, specifically 0.001 to 0.3 parts by weight, and more specifically 0.001 to 0.1 parts by weight. When the cooling agent is included in the above range, it can provide a better cooling sensation, prevent skin damage, soothe the skin, and exert skin barrier protection effects.
상기 화장료 조성물은 상기 진정제 및 쿨링제를 1:0.05 내지 1:0.5의 중량비로 포함할 수 있고, 구체적으로 1:0.05 내지 1:0.3, 더욱 구체적으로 1:0.05 내지 1:0.12의 중량비로 포함할 수 있다. 상기 진정제 및 쿨링제가 상기 중량비로 포함될 경우, 항산화 효과, 항염 효과 및 광노화 방지 효과와 쿨링감 부여, 피부 손상방지, 피부 진정 및 피부 장벽 보호 효과가 더욱 적절히 조화를 이룰 수 있다. The cosmetic composition may include the sedative and cooling agent at a weight ratio of 1:0.05 to 1:0.5, specifically 1:0.05 to 1:0.3, and more specifically 1:0.05 to 1:0.12. You can. When the sedative and cooling agent are included in the above weight ratio, the antioxidant effect, anti-inflammatory effect, anti-photoaging effect, cooling sensation, skin damage prevention, skin soothing, and skin barrier protection effect can be more appropriately harmonized.
본 명세서에서 용어 “스킨-팩터스 10(skin-factors 10)”은 수화 콜라겐, 콜라겐, 소듐히알루로네이트, 세라마이드 NP, 하이드롤라이즈드엘라스틴, sh-올리고펩타이드-1, 락토바실러스 발효물, 글라이코사미노글리칸, 유비퀴논, 멜라토닌, 및 글루타치온으로 이루어진 조성물을 의미하며, 상기 스킨-팩터스 10은 노화에 의해 피부에서 줄어드는 10가지 성분들의 조성물로서, 노화에 의해 피부에서 줄어드는 상기 10가지 성분들을 보충하여 노화된 피부를 개선하는 효과를 발휘할 수 있다. As used herein, the term “skin-factors 10” refers to hydrated collagen, collagen, sodium hyaluronate, ceramide NP, hydrolyzed elastin, sh-oligopeptide-1, Lactobacillus ferment, text. It refers to a composition consisting of lycosaminoglycan, ubiquinone, melatonin, and glutathione, and the Skin-Factors 10 is a composition of 10 ingredients that are reduced in the skin due to aging. It can be effective in improving aged skin by supplementing with it.
상기 스킨-팩터스 10을 구성하는 수화 콜라겐 및 콜라겐은 체내에서 생성되지 않는 콜라겐을 외부에서 공급하여 피부 탄력 저하 억제에 도움을 줄 수 있고, 콜라겐의 생합성을 촉진하여 진피층의 탄력을 증가시킴으로써 피부의 주름을 예방하며 피부 재생 촉진에 도움을 줄 수 있다. 또한, 상기 소듐히알루로네이트는 피부에 수분을 부여하고 우수한 보습 효과를 제공할 수 있고, 상기 유비퀴논은 세포 내 에너지 생성을 돕고 항산화 효과를 나타낼 수 있다. The hydrated collagen and collagen that make up Skin-Factors 10 can help suppress the decline in skin elasticity by supplying collagen that is not produced in the body from outside, and increase the elasticity of the dermal layer by promoting collagen biosynthesis, thereby improving the elasticity of the skin. It can help prevent wrinkles and promote skin regeneration. In addition, the sodium hyaluronate can moisturize the skin and provide an excellent moisturizing effect, and the ubiquinone can help generate intracellular energy and have an antioxidant effect.
상기 스킨-팩터스 10은 상기 화장료 조성물에 0.01 내지 0.5 중량부 포함되며, 구체적으로 0.001 내지 0.3 중량부, 더욱 구체적으로 0.001 내지 0.1 중량부 포함될 수 있다.The Skin-Factors 10 may be included in the cosmetic composition in an amount of 0.01 to 0.5 parts by weight, specifically 0.001 to 0.3 parts by weight, and more specifically 0.001 to 0.1 parts by weight.
상기 화장료 조성물은 상기 스킨-팩터 10을 상기 쿨링제 및 진정제의 합계량 100 중량부에 대하여 100 중량부 내지 150 중량부, 구체적으로 100 중량부 내지 130 중량부의 양으로 포함할 수 있다. 상기 쿨링제 및 진정제의 합계량에 대한 상기 스킨-팩터 10의 함량이 상기 범위를 만족할 경우, 피부 쿨링 및 진정 효과와 함께 노화된 피부의 개선 효과를 발휘할 수 있다. The cosmetic composition may include the Skin-Factor 10 in an amount of 100 to 150 parts by weight, specifically 100 to 130 parts by weight, based on 100 parts by weight of the total amount of the cooling agent and the sedative. When the content of Skin-Factor 10 relative to the total amount of the cooling agent and soothing agent satisfies the above range, it can exert a skin cooling and soothing effect as well as an improvement effect on aged skin.
상기 화장료 조성물은 추가로 용매를 30 내지 40 중량부 포함할 수 있고, 구체적으로 32 내지 38 중량부, 더욱 구체적으로 33 내지 36 중량부 포함할 수 있다. 상기 용매가 상기 범위로 포함될 경우, 상기 화장료 조성물이 우수한 발림성을 발휘할 수 있고, 적절한 수분을 포함할 수 있다. The cosmetic composition may additionally contain 30 to 40 parts by weight of solvent, specifically 32 to 38 parts by weight, and more specifically 33 to 36 parts by weight. When the solvent is contained within the above range, the cosmetic composition can exhibit excellent spreadability and contain appropriate moisture.
본 발명의 화장료 조성물은 용매로서 물, 알킬렌글라이콜, 및 알킬디올을 포함하고, 구체적으로 물, 다이프로필렌글라이콜, 1,2-헥산다이올, 프로판다이올, 부틸렌글라이콜 또는 이들의 혼합물을 포함할 수 있다.The cosmetic composition of the present invention contains water, alkylene glycol, and alkyldiol as solvents, and specifically, water, dipropylene glycol, 1,2-hexanediol, propanediol, butylene glycol, or these. It may include a mixture of.
상기 화장료 조성물은 추가로 계면활성제 3 내지 6 중량부를 포함할 수 있고, 구체적으로 추가로 계면활성제 4 내지 5.5 중량부를 포함할 수 있다. The cosmetic composition may additionally include 3 to 6 parts by weight of a surfactant, and specifically, may additionally include 4 to 5.5 parts by weight of a surfactant.
또한, 상기 계면활성제는 라우릴 PEG-10 트리스(트라이메틸실록시)실릴에틸다이메티콘, 세틸 PEG/PPG-10/1다이메티콘, 솔비탄 세스퀴올리에이트, 스테아린산, 및 칸디다 봄비콜라/글루코오스/메틸레이프씨데이트 발효물을 포함할 수 있다. In addition, the surfactant includes lauryl PEG-10 tris(trimethylsiloxy)silylethyldimethicone, cetyl PEG/PPG-10/1 dimethicone, sorbitan sesquioleate, stearic acid, and Candida bombicola/ May contain glucose/methylrapcidate fermentation.
또한, 본 발명의 화장료 조성물은 향료, 안료, 불투명화제, 고화방지제, 보존제, 및 킬레이팅제로 이루어진 군으로부터 선택된 1종 이상을 추가로 포함할 수 있다. In addition, the cosmetic composition of the present invention may further include one or more selected from the group consisting of fragrance, pigment, opacifying agent, anti-caking agent, preservative, and chelating agent.
본 발명의 색조 화장료 조성물은 안료를 0.5 중량부 내지 5 중량부 포함할 수 있고, 구체적으로 0.7 중량부 내지 3 중량부, 더욱 구체적으로 0.8 중량부 내지 2 중량부 포함할 수 있다. 상기 안료로는 예컨대 황색 203호, 황색 4호, 황색 5호, 황색 201호, 황색 204호, 적색 103호, 적색 201호, 적색 202호, 적색 218호, 적색 220호, 적색 223호, 적색 226호, 적색 227호, 청색 1호, 청색 2호 등의 바륨 또는 알루미늄 레이크의 유기 안료, 진주 안료, 운모, 합성운모, 견운모, 카올린, 산화티탄피복 운모, 알루미늄 파우더, 흑산화철, 카본블랙, 황산바륨, 실리카 및 제올라이트 등의 무기 파우더; 및 나일론, PMMA, 폴리스틸렌 파우더, 폴리에틸렌 파우더 및 셀룰로오스 파우더 등의 유기 파우더를 들 수 있다. The color cosmetic composition of the present invention may contain 0.5 to 5 parts by weight of pigment, specifically 0.7 to 3 parts by weight, and more specifically 0.8 to 2 parts by weight. The above pigments include, for example, Yellow No. 203, Yellow No. 4, Yellow No. 5, Yellow No. 201, Yellow No. 204, Red No. 103, Red No. 201, Red No. 202, Red No. 218, Red No. 220, Red No. 223, Red No. Organic pigments of barium or aluminum lake such as No. 226, Red No. 227, Blue No. 1, and Blue No. 2, pearl pigments, mica, synthetic mica, sericite, kaolin, titanium oxide-coated mica, aluminum powder, black iron oxide, carbon black, Inorganic powders such as barium sulfate, silica, and zeolite; and organic powders such as nylon, PMMA, polystyrene powder, polyethylene powder, and cellulose powder.
상기 선 스크린제로 포함되는 티타늄 디옥사이드는 상기 안료로서 함께 작용할 수 있으나, 상기 예시한 안료의 함량에 상기 티타늄 디옥사이드의 함량은 포함되지 않는다. Titanium dioxide included in the sunscreen agent may act as the pigment, but the content of titanium dioxide is not included in the content of the exemplified pigment.
상기 향료, 불투명화제, 고화방지제, 보존제, 및 킬레이팅제로는 당분야에서 통상적으로 사용되는 것들이 사용될 수 있다. The flavoring agent, opacifying agent, anti-caking agent, preservative, and chelating agent may be those commonly used in the art.
본 발명의 색조 화장료 조성물은 통상의 제조방법에 의하여 가열, 혼합 및 교반 등의 처리에 의해 제형화될 수 있고, 팩트, 트리트먼트, 크림, 에멀젼, 로션 등을 제조하기 위한 화장료 조성물로서 사용될 수 있다. The color cosmetic composition of the present invention can be formulated by processing such as heating, mixing, and stirring according to a conventional manufacturing method, and can be used as a cosmetic composition for manufacturing compacts, treatments, creams, emulsions, lotions, etc. .
이하, 본 발명을 구체적으로 설명하기 위해 실시예 및 실험예를 들어 상세하게 설명한다. 그러나, 본 발명의 범위가 아래에서 상술하는 실시예 및 실험예에 한정되지 않으며 여러 가지 다른 형태로 변형될 수 있다. Hereinafter, the present invention will be described in detail with reference to examples and experimental examples. However, the scope of the present invention is not limited to the examples and experimental examples described in detail below, and may be modified into various other forms.
이하, 본 발명을 구체적으로 설명하기 위해 실시예 및 실험예를 들어 상세하게 설명한다. 그러나, 본 발명의 범위가 아래에서 상술하는 실시예 및 실험예에 한정되지 않으며 여러 가지 다른 형태로 변형될 수 있다. Hereinafter, the present invention will be described in detail with reference to examples and experimental examples. However, the scope of the present invention is not limited to the examples and experimental examples described in detail below, and may be modified into various other forms.
실시예 1 내지 5, 및 비교예 1 내지 5Examples 1 to 5, and Comparative Examples 1 to 5
하기 표 1 및 2의 조성을 갖는 화장료 조성물을 제조하였다. Cosmetic compositions having the compositions shown in Tables 1 and 2 below were prepared.
표 1의 각 성분 및 함량(중량%)에 따라 비커에 평량하여 85℃로 가열 용해한 후, 호모게나이저를 이용하여 2,500 rpm에서 15분간 균일하게 혼합하였다. 제조된 혼합물을 탈기, 부향하고 10분간 냉각하여 화장료 조성물을 제조하였다.According to each component and content (% by weight) in Table 1, it was weighed in a beaker, heated and dissolved at 85°C, and then mixed uniformly at 2,500 rpm for 15 minutes using a homogenizer. The prepared mixture was degassed, perfumed, and cooled for 10 minutes to prepare a cosmetic composition.
1Example
One
2Example
2
3Example
3
1Comparative example
One
2Comparative example
2
다이페닐실록시페닐트리메티콘, 페닐트리메티콘, 아스코빅산, 나이아신아미드, 프로필렌글리콜다이벤조에이트, 시클로펜타실록산, 디메티콘, 로릴 라이신, 트리베헤닌, 글리세릴베헤네이트/에이코사디오에이트, 디소듐스테아로일글루타메이트, 에틸헥실글리세린, 디아이소스테아릴말레이트Ascorbic acid, pantolactone, centella asiatica extract, sunflower seed oil, xylitol, anhydrous xylitol, hydrated lecithin, niacinamide, panthenol, adenosine, hyaluronic acid, and hydrated hyaluronic acid.
Diphenylsiloxyphenyltrimethicone, phenyltrimethicone, ascorbic acid, niacinamide, propylene glycol dibenzoate, cyclopentasiloxane, dimethicone, lauryl lysine, tribehenin, glyceryl behenate/eicosadioate, Disodium Stearoyl Glutamate, Ethylhexyl Glycerin, Diisostearyl Maleate
트라이메틸실록시실리케이트
글리세린
디에틸아미노하이드록시벤조일헥실벤조에이트
트로메타민
폴리메틸실세스퀴옥세인
아크릴레이트/스테아릴아크릴레이트/다이메티콘메타크릴레이트코폴리머
마그네슘설페이트
다이스테아다이모늄헥토라이트
알루미늄하이드록사이드
소듐벤조에이트
트라이에톡시카프릴릴실레인
다이메티콘/비닐다이메티콘크로스폴리머
알루미나
포타슘솔베이트
트라이소듐에틸렌다이아민다이석시네이트
펜타에리스리틸테트라-다이-t-부틸하이드록시하이드로신나메이트
토코페롤
씨대퍼딜추출물
펜타에리스리틸테트라-다이-t-부틸하이드록시하이드로신나메이트, 토코페롤Acrylate/dimethicone copolymer
Trimethylsiloxysilicate
glycerin
Diethylaminohydroxybenzoylhexylbenzoate
Tromethamine
Polymethylsilsesquioxane
Acrylate/stearyl acrylate/dimethicone methacrylate copolymer
Magnesium sulfate
Disteadimonium hectorite
aluminum hydroxide
Sodium Benzoate
Triethoxycaprylylsilane
Dimethicone/Vinyl Dimethicone Crosspolymer
alumina
Potassium Sorbate
Trisodium Ethylenediamine Disuccinate
Pentaerythrityltetra-di-t-butylhydroxyhydrocinnamate
tocopherol
Seed dapper dill extract
Pentaerythrityltetra-di-t-butylhydroxyhydrocinnamate, tocopherol
적색산화철
흑색산화철yellow iron oxide
red iron oxide
black iron oxide
실험예Experiment example
관능 평가Sensory evaluation
상기 실시예 1 내지 3과 비교예 1 및 2에서 각각 제조된 화장료 조성물을 팩트 형태로 제조하여, 이에 대해 35∼50세 여성으로서 일주일에 최소 5회 이상 지속적으로 팩트 제품을 사용하는 패널 10명을 대상으로 항목별 5점 척도(1점: 아주 나쁨, 2점: 나쁨, 3점: 보통, 4점: 좋음, 5점: 아주 좋음)으로 비교 평가하였다. 그 결과를 하기 표 2에 나타내었다. The cosmetic compositions prepared in Examples 1 to 3 and Comparative Examples 1 and 2 were prepared in the form of a pact, and 10 panelists who were 35 to 50 years old and consistently used the pact product at least 5 times a week were selected. Each item was compared and evaluated on a 5-point scale (1 point: very bad, 2 points: bad, 3 points: average, 4 points: good, 5 points: very good). The results are shown in Table 2 below.
(4주후)Skin improvement
(4 weeks later)
실시예 1 내지 3의 화장료 조성물을 이용하여 제조된 팩트는 사용자의 관능평가에서 커버력, 발림성 및 사용감이 고르게 우수하였으며, 사용자가 4주 지속 사용 후 느끼는 피부 개선감 역시 우수하였다. The pacts manufactured using the cosmetic compositions of Examples 1 to 3 were uniformly excellent in covering power, spreadability, and feeling of use in the user's sensory evaluation, and the feeling of skin improvement felt by the user after continuous use for 4 weeks was also excellent.
반면, 비교예 1 및 2의 화장료 조성물을 이용하여 제조된 팩트는 사용자의 관능평가에서 커버력, 발림성 및 사용감은 실시예 1 내지 3과 비슷한 수준이었지만, 사용자가 4주 지속 사용 후 느끼는 피부 개선감은 보통 수준으로 사용자가 특별한 개선감을 느끼지는 못한 것으로 확인되었다. On the other hand, the covering power, spreadability, and feeling of use of the pact manufactured using the cosmetic compositions of Comparative Examples 1 and 2 were similar to those of Examples 1 to 3 in the user's sensory evaluation, but the feeling of skin improvement felt by the user after continuous use for 4 weeks was average. It was confirmed that users did not feel any particular sense of improvement.
Claims (12)
상기 스킨 컨디셔닝제를 15 내지 25 중량부, 상기 선 스크린제를 20 내지 30 중량부, 상기 진정제를 0.001 내지 0.1 중량부, 상기 쿨링제를 0.01 내지 0.5 중량부, 상기 스킨-팩터스 10을 0.01 내지 0.5 중량부 포함하고,
상기 스킨 컨디셔닝제는 아스코빅산, 판토락톤, 병풀추출물, 해바라기씨 오일, 자일리톨, 무수자일리톨, 수화 레시틴, 나이아신아미드, 판테놀, 아데노신, 히알루론산, 및 수화 히알루론산을 포함하고,
상기 선 스크린제는 티타늄디옥사이드, 호모살레이트, 및 페닐벤즈이미다졸설폰산을 포함하고,
상기 진정제는 카카오씨 추출물, 커피콩 추출물, 월계수잎 추출물 및 유칼리투스잎 추출물을 포함하고,
상기 쿨링제는 알로에베라잎 추출물, 참마뿌리 추출물, 다시마 추출물, 당느릅나무뿌리 추출물 및 제비꽃 꽃추출물을 포함하며,
상기 스킨-팩터스 10은 수화 콜라겐, 콜라겐, 소듐히알루로네이트, 세라마이드 NP, 하이드롤라이즈드엘라스틴, sh-올리고펩타이드-1, 락토바실러스발효물, 글라이코사미노글리칸, 유비퀴논, 멜라토닌, 및 글루타치온으로 이루어지되,
상기 스킨 컨디셔닝제는 추가로 다이페닐실록시페닐트리메티콘, 페닐트리메티콘, 아스코빅산, 나이아신아미드, 프로필렌글리콜다이벤조에이트, 시클로펜타실록산, 디메티콘, 로릴 라이신, 트리베헤닌, 글리세릴베헤네이트/에이코사디오에이트, 디소듐스테아로일글루타메이트, 에틸헥실글리세린, 및 디아이소스테아릴말레이트를 포함하는 화장료 조성물.
A cosmetic composition comprising a skin conditioning agent, a sunscreen agent, a soothing agent, a cooling agent, and Skin-Factor 10,
15 to 25 parts by weight of the skin conditioning agent, 20 to 30 parts by weight of the sunscreen, 0.001 to 0.1 parts by weight of the sedative, 0.01 to 0.5 parts by weight of the cooling agent, and 0.01 to 0.01 to 0.01 parts by weight of the Skin-Factors 10. Contains 0.5 parts by weight,
The skin conditioning agent includes ascorbic acid, pantholactone, centella asiatica extract, sunflower seed oil, xylitol, anhydrous xylitol, hydrated lecithin, niacinamide, panthenol, adenosine, hyaluronic acid, and hydrated hyaluronic acid,
The sunscreen agent includes titanium dioxide, homosalate, and phenylbenzimidazolesulfonic acid,
The sedative agent includes cacao seed extract, coffee bean extract, bay leaf extract, and eucalyptus leaf extract,
The cooling agent includes aloe vera leaf extract, yam root extract, kelp extract, elm root extract, and violet flower extract,
The Skin-Factors 10 contains hydrating collagen, collagen, sodium hyaluronate, ceramide NP, hydrolyzed elastin, sh-oligopeptide-1, Lactobacillus ferment, glycosaminoglycan, ubiquinone, melatonin, and glutathione,
The skin conditioning agent further includes diphenylsiloxyphenyltrimethicone, phenyltrimethicone, ascorbic acid, niacinamide, propylene glycol dibenzoate, cyclopentasiloxane, dimethicone, lauryl lysine, tribehenin, and glyceryl behe. A cosmetic composition comprising nate/eicosadioate, disodium stearoyl glutamate, ethylhexylglycerin, and diisostearyl maleate.
상기 진정제는 카카오씨 추출물, 커피콩 추출물, 월계수잎 추출물 및 유칼리투스잎 추출물을 1:1:1:1의 중량비로 포함하는 화장료 조성물.
According to claim 1,
The sedative is a cosmetic composition comprising cacao seed extract, coffee bean extract, bay leaf extract, and eucalyptus leaf extract in a weight ratio of 1:1:1:1.
상기 쿨링제는 알로에베라잎 추출물, 참마뿌리 추출물, 다시마 추출물, 당느릅나무뿌리 추출물 및 제비꽃 꽃추출물을 1:1:1:1:1의 중량비로 포함하는 화장료 조성물.
According to claim 1,
The cooling agent is a cosmetic composition comprising aloe vera leaf extract, yam root extract, kelp extract, elm root extract, and violet flower extract in a weight ratio of 1:1:1:1:1.
상기 화장료 조성물은 상기 쿨링제 및 진정제를 1:0.05 내지 1:0.5의 중량비로 포함하는 화장료 조성물,
According to claim 1,
The cosmetic composition includes the cooling agent and the soothing agent in a weight ratio of 1:0.05 to 1:0.5,
상기 화장료 조성물은 상기 스킨-팩터스 10을 상기 쿨링제 및 진정제의 합계량 100 중량부에 대하여 100 중량부 내지 150 중량부의 양으로 포함하는 화장료 조성물.
According to claim 1,
The cosmetic composition includes the Skin-Factors 10 in an amount of 100 to 150 parts by weight based on 100 parts by weight of the total amount of the cooling agent and the sedative.
상기 화장료 조성물은 추가로 용매 30 내지 40 중량부를 포함하는 화장료 조성물.
According to claim 1,
The cosmetic composition further includes 30 to 40 parts by weight of a solvent.
상기 용매는 물, 알킬렌글라이콜, 및 알킬디올을 포함하는 화장료 조성물.
According to claim 7,
A cosmetic composition wherein the solvent includes water, alkylene glycol, and alkyldiol.
상기 화장료 조성물은 추가로 계면활성제 3 내지 6 중량부를 포함하는 화장료 조성물.
According to claim 1,
The cosmetic composition further includes 3 to 6 parts by weight of a surfactant.
상기 계면활성제는 라우릴 PEG-10 트리스(트라이메틸실록시)실릴에틸다이메티콘, 세틸 PEG/PPG-10/1다이메티콘, 솔비탄 세스퀴올리에이트, 스테아린산, 및 칸디다 봄비콜라/글루코오스/메틸레이프씨데이트 발효물을 포함하는 화장료 조성물.
According to clause 9,
The surfactant includes lauryl PEG-10 tris(trimethylsiloxy)silylethyldimethicone, cetyl PEG/PPG-10/1 dimethicone, sorbitan sesquioleate, stearic acid, and Candida bombicola/glucose/ A cosmetic composition containing fermented methyl lepcidate.
상기 화장료 조성물은 향료, 안료, 항산화제, 불투명화제, 고화방지제, 보존제, 및 킬레이팅제로 이루어진 군으로부터 선택된 1종 이상을 추가로 포함하는 화장료 조성물.
According to claim 1,
The cosmetic composition further comprises at least one selected from the group consisting of fragrance, pigment, antioxidant, opacifying agent, anti-caking agent, preservative, and chelating agent.
상기 화장료 조성물은 팩트, 트리트먼트, 크림, 에멀젼, 또는 로션인 화장료 조성물.
According to claim 1,
The cosmetic composition is a pact, treatment, cream, emulsion, or lotion.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| KR1020230083884A KR102591077B1 (en) | 2023-06-29 | 2023-06-29 | Cosmetic composition |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| KR1020230083884A KR102591077B1 (en) | 2023-06-29 | 2023-06-29 | Cosmetic composition |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| KR102591077B1 true KR102591077B1 (en) | 2023-10-20 |
Family
ID=88514475
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| KR1020230083884A KR102591077B1 (en) | 2023-06-29 | 2023-06-29 | Cosmetic composition |
Country Status (1)
| Country | Link |
|---|---|
| KR (1) | KR102591077B1 (en) |
Citations (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2013533220A (en) * | 2010-06-03 | 2013-08-22 | ロレアル | Cosmetic treatment method using a coating based on a copolymer containing polyamide blocks and polyether blocks |
| KR20200143515A (en) * | 2012-12-27 | 2020-12-23 | 가부시기가이샤하야시바라 | Skin-exterior anti-ageing composition and production method therefor |
| KR20200144904A (en) | 2019-06-19 | 2020-12-30 | (주)아모레퍼시픽 | Cosmetic composition capable of mixed using for adjusting chroma |
| KR102242215B1 (en) * | 2021-01-08 | 2021-04-20 | (주)비엔 | Color cosmetic composition comprising color base and extract reacted with enzyme of low temperature and high pressure |
| US20220071883A1 (en) * | 2016-07-15 | 2022-03-10 | Medicell Technologies, Llc | Compositions and methods for modifying hair color |
| KR102506839B1 (en) * | 2022-08-25 | 2023-03-07 | 이에스코스메틱 주식회사 | Gel-type cosmetic composition for spraying |
| KR20230077180A (en) | 2021-11-25 | 2023-06-01 | 주식회사 코리아나화장품 | Surfactant-free liquid cosmetic composition for uv blocking |
-
2023
- 2023-06-29 KR KR1020230083884A patent/KR102591077B1/en active IP Right Grant
Patent Citations (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2013533220A (en) * | 2010-06-03 | 2013-08-22 | ロレアル | Cosmetic treatment method using a coating based on a copolymer containing polyamide blocks and polyether blocks |
| KR20200143515A (en) * | 2012-12-27 | 2020-12-23 | 가부시기가이샤하야시바라 | Skin-exterior anti-ageing composition and production method therefor |
| US20220071883A1 (en) * | 2016-07-15 | 2022-03-10 | Medicell Technologies, Llc | Compositions and methods for modifying hair color |
| KR20200144904A (en) | 2019-06-19 | 2020-12-30 | (주)아모레퍼시픽 | Cosmetic composition capable of mixed using for adjusting chroma |
| KR102242215B1 (en) * | 2021-01-08 | 2021-04-20 | (주)비엔 | Color cosmetic composition comprising color base and extract reacted with enzyme of low temperature and high pressure |
| KR20230077180A (en) | 2021-11-25 | 2023-06-01 | 주식회사 코리아나화장품 | Surfactant-free liquid cosmetic composition for uv blocking |
| KR102506839B1 (en) * | 2022-08-25 | 2023-03-07 | 이에스코스메틱 주식회사 | Gel-type cosmetic composition for spraying |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US11833242B2 (en) | Skin care formulations | |
| US20080206172A1 (en) | Clear sunscreen gels and methods of use thereof | |
| KR101068276B1 (en) | Clear sunscreen gels and methods of use thereof | |
| US20150202139A1 (en) | Anti-aging skincare products | |
| US9913785B2 (en) | Topical chicory extract skin care composition providing broad spectrum sunscreen | |
| US20150202145A1 (en) | Sunscreen composition with improved aesthetic properties | |
| CN112656729A (en) | Oil control isolation composition and preparation method and application thereof | |
| CN113509408A (en) | Skin-care composite essential oil | |
| CN112472629A (en) | Alpinia officinarum and amomum tsao-ko sun-proof emulsion and preparation method thereof | |
| KR102591077B1 (en) | Cosmetic composition | |
| KR102027647B1 (en) | Low irritating cosmetic composition for skin whitening comprising albutin | |
| KR101919116B1 (en) | Water-in-Oil Cosmetic Composition with Shape-Memory Ability | |
| CN115024994A (en) | High-safety sunscreen composition and preparation method and application thereof | |
| JPH09136822A (en) | Antiaging preparation for external use for skin, preparation for external use for skin capable of inhibiting cross-linking of collagen and antiultraviolet ray preparation for external use for skin | |
| JPH09136823A (en) | Antiaging preparation for external use for skin, preparation for external use for skin capable of inhibiting cross-linking of collagen and antiultraviolet ray preparation for external use for skin | |
| CN112263525A (en) | Natural cosmetic with whitening effect | |
| KR102354352B1 (en) | Oil-in- water cosmetic composition comprising physical sunscreen | |
| JP2003306410A (en) | Powder-containing water in oil type emulsion cosmetic | |
| JP2005170860A (en) | Skin care preparation for external use | |
| KR102291076B1 (en) | Cosmetic composition containing Mentyl PCA and Ginger extract | |
| KR102419912B1 (en) | Mist type sunscreen cosmetic composition | |
| KR102501405B1 (en) | A cosmetic composition having lasting moisturizing effects and a method for manufacturing the same | |
| KR102621818B1 (en) | Water in oil type cosmetic composition | |
| KR102223208B1 (en) | Cosmetic composition for anti-wrinkles and preventing white cast | |
| JPH09175980A (en) | Cosmetic |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| E902 | Notification of reason for refusal | ||
| E701 | Decision to grant or registration of patent right | ||
| GRNT | Written decision to grant |